Opioid Pharmacy Lawsuit: The $13 Billion Pharmacy Settlement

The Claims

As the opioid epidemic killed hundreds of thousands of Americans, litigation expanded beyond drugmakers and distributors to the retail pharmacies that dispensed the pills. States, counties and cities alleged that CVS, Walgreens and Walmart — the three largest US pharmacy chains — failed to maintain adequate controls to spot and stop suspicious opioid prescriptions, helping flood communities with addictive painkillers. The theory was that pharmacies are a last line of defense and had a duty to flag red flags like implausible quantities or prescribers.

This pharmacy litigation was part of a broader wave that also produced multibillion-dollar settlements with manufacturers and distributors.

The Settlement

In late 2022, the three chains agreed in principle to settlements totaling more than $13 billion — roughly $5 billion from CVS, $5.7 billion from Walgreens and $3.1 billion from Walmart — paid out over periods of a decade or more. Like other opioid settlements, most of the money is directed to state and local governments to fund abatement: addiction treatment, recovery support, overdose-reversal medication and prevention. The deals also required the chains to strengthen how they monitor and dispense opioids.

Importantly, these funds flow to governments and public programs, not to individuals as personal injury payouts.

What to Know

If you or a family member were harmed by the opioid crisis, this settlement does not offer a personal claim to file — the recovery is public, meant to fund treatment and prevention in communities. Individuals seeking help can access those state-funded treatment and recovery resources. Anyone told they can collect a personal check from the pharmacy opioid settlement should be skeptical.